Out-of-pocket costs for infliximab and its biosimilar for rheumatoid arthritis under medicare part d

Jinoos Yazdany, R. Adams Dudley, Grace A. Lin, Randi Chen, Chien Wen Tseng

Research output: Contribution to journal › Letter › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Out-of-pocket costs for infliximab and its biosimilar for rheumatoid arthritis under medicare part d'. Together they form a unique fingerprint.